FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1648827754> ?p ?o ?g. }

• W1648827754 endingPage "1285" @default.
• W1648827754 startingPage "1277" @default.
• W1648827754 abstract "It was shown that the proteasome inhibitor, bortezomib, administered immediately following allogeneic bone marrow transplantation resulted in marked inhibition of acute graft-versus-host disease (aGVHD), with retention of graft-versus-tumor effects. However, continuous bortezomib administration resulted in significant acceleration of graft-versus-host disease-dependent morbidity. We carried out studies to dissect the mechanisms of aggravated aGVHD caused by delayed bortezomib administration. First, we demonstrated that IL-1β was critically involved, and the subsequent aGVHD could be alleviated by IL-1β blockade. Bortezomib treatment after dendritic cell (DC) activation resulted in drastically elevated IL-1β production, whereas bortezomib treatment before DC activation inhibited IL-1β production, suggesting that the timing of bortezomib administration significantly affected IL-1β production by DCs. We further demonstrated that delayed administration of bortezomib accelerated aGVHD through TLR4 signaling. Because the LPS levels were much lower with reduced-intensity conditioning compared with high-dose irradiation, the accelerated graft-versus-host disease-dependent morbidity with delayed bortezomib administration could be rescued by reduced-intensity conditioning. Our studies suggested that TLR4 pathway activation and delayed bortezomib administration amplified the production of IL-1β and other inflammatory cytokines, which resulted in accelerated aGVHD-dependent morbidity. These results indicated that decreased toxicity of continuous bortezomib administration could be achieved by reduced-intensity conditioning or by inhibiting IL-1β." @default.
• W1648827754 created "2016-06-24" @default.
• W1648827754 creator A5002430497 @default.
• W1648827754 creator A5004290396 @default.
• W1648827754 creator A5014059510 @default.
• W1648827754 creator A5018863416 @default.
• W1648827754 creator A5024851990 @default.
• W1648827754 creator A5040504895 @default.
• W1648827754 creator A5047951366 @default.
• W1648827754 creator A5056445856 @default.
• W1648827754 creator A5077384746 @default.
• W1648827754 creator A5088112325 @default.
• W1648827754 date "2014-02-01" @default.
• W1648827754 modified "2023-09-22" @default.
• W1648827754 title "IL-1β and TLR4 Signaling Are Involved in the Aggravated Murine Acute Graft-versus-Host Disease Caused by Delayed Bortezomib Administration" @default.
• W1648827754 cites W1544569979 @default.
• W1648827754 cites W1571910978 @default.
• W1648827754 cites W1608695296 @default.
• W1648827754 cites W1640850701 @default.
• W1648827754 cites W1868543645 @default.
• W1648827754 cites W1920417226 @default.
• W1648827754 cites W1968856388 @default.
• W1648827754 cites W1969072247 @default.
• W1648827754 cites W1977166918 @default.
• W1648827754 cites W1978025330 @default.
• W1648827754 cites W1980841426 @default.
• W1648827754 cites W1986843752 @default.
• W1648827754 cites W1992841021 @default.
• W1648827754 cites W1994391392 @default.
• W1648827754 cites W2001921163 @default.
• W1648827754 cites W2002330167 @default.
• W1648827754 cites W2004657695 @default.
• W1648827754 cites W2005584838 @default.
• W1648827754 cites W2007667352 @default.
• W1648827754 cites W2010219741 @default.
• W1648827754 cites W2013750592 @default.
• W1648827754 cites W2029533049 @default.
• W1648827754 cites W2052605694 @default.
• W1648827754 cites W2059699981 @default.
• W1648827754 cites W2064411005 @default.
• W1648827754 cites W2078486900 @default.
• W1648827754 cites W2078514942 @default.
• W1648827754 cites W2087521550 @default.
• W1648827754 cites W2087613277 @default.
• W1648827754 cites W2090640877 @default.
• W1648827754 cites W2090653170 @default.
• W1648827754 cites W2091426910 @default.
• W1648827754 cites W2093452703 @default.
• W1648827754 cites W2103077094 @default.
• W1648827754 cites W2107396956 @default.
• W1648827754 cites W2109168421 @default.
• W1648827754 cites W2118886727 @default.
• W1648827754 cites W2120428769 @default.
• W1648827754 cites W2126397566 @default.
• W1648827754 cites W2133590829 @default.
• W1648827754 cites W2138210036 @default.
• W1648827754 cites W2139823699 @default.
• W1648827754 cites W2144789671 @default.
• W1648827754 cites W2148178789 @default.
• W1648827754 cites W2155940448 @default.
• W1648827754 cites W2161208630 @default.
• W1648827754 cites W2166781237 @default.
• W1648827754 cites W299320663 @default.
• W1648827754 doi "https://doi.org/10.4049/jimmunol.1203428" @default.
• W1648827754 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24363427" @default.
• W1648827754 hasPublicationYear "2014" @default.
• W1648827754 type Work @default.
• W1648827754 sameAs 1648827754 @default.
• W1648827754 citedByCount "28" @default.
• W1648827754 countsByYear W16488277542015 @default.
• W1648827754 countsByYear W16488277542016 @default.
• W1648827754 countsByYear W16488277542017 @default.
• W1648827754 countsByYear W16488277542018 @default.
• W1648827754 countsByYear W16488277542019 @default.
• W1648827754 countsByYear W16488277542020 @default.
• W1648827754 countsByYear W16488277542021 @default.
• W1648827754 countsByYear W16488277542022 @default.
• W1648827754 countsByYear W16488277542023 @default.
• W1648827754 crossrefType "journal-article" @default.
• W1648827754 hasAuthorship W1648827754A5002430497 @default.
• W1648827754 hasAuthorship W1648827754A5004290396 @default.
• W1648827754 hasAuthorship W1648827754A5014059510 @default.
• W1648827754 hasAuthorship W1648827754A5018863416 @default.
• W1648827754 hasAuthorship W1648827754A5024851990 @default.
• W1648827754 hasAuthorship W1648827754A5040504895 @default.
• W1648827754 hasAuthorship W1648827754A5047951366 @default.
• W1648827754 hasAuthorship W1648827754A5056445856 @default.
• W1648827754 hasAuthorship W1648827754A5077384746 @default.
• W1648827754 hasAuthorship W1648827754A5088112325 @default.
• W1648827754 hasBestOaLocation W16488277541 @default.
• W1648827754 hasConcept C126322002 @default.
• W1648827754 hasConcept C170493617 @default.
• W1648827754 hasConcept C203014093 @default.
• W1648827754 hasConcept C2776070231 @default.
• W1648827754 hasConcept C2776364478 @default.
• W1648827754 hasConcept C2777478702 @default.
• W1648827754 hasConcept C2778367456 @default.
• W1648827754 hasConcept C2778468042 @default.

• next